RBC Capital Maintains Outperform on DRI Healthcare Trust, Raises Price Target to C$22
RBC Capital analyst Douglas Miehm maintains DRI Healthcare Trust (TSX:DHT) with a Outperform and raises the price target from C$21 to C$22.
Share
Why It Matters
An expert investor watcher believes DHT Healthcare Trust is a good pick. They raised their price target from C$21 to C$22 per share.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.